The programmed cell death 4 (PDCD4) gene was originally identified as a tumor-related gene in humans and acts as a tumor-suppressor in mouse epidermal carcinoma cells. However, its function and regulatory mechanisms of expression in human cancer remain to be elucidated. We therefore investigated the expression of PDCD4 in human hepatocellular carcinoma (HCC) and the role of PDCD4 in human HCC cells. Downregulation of PDCD4 protein was observed in all HCC tissues tested compared with corresponding noncancerous liver, as revealed by Western blotting or immunohistochemical staining. Human HCC cell line, Huh7, transfected with PDCD4 cDNA showed nuclear fragmentation and DNA laddering characteristic of apoptotic cells associated with mitochondrial changes and caspase activation. Transforming growth factor-b1 (TGF-b1) treatment of Huh7 cells resulted in increased PDCD4 expression and occurrence of apoptosis, also concomitant with mitochondrial events and caspase activation. Transfection of Smad7, a known antagonist to TGF-b1 signaling, protected cells from TGF-b1-mediated apoptosis and suppressed TGF-b1-induced PDCD4 expression. Moreover, antisense PDCD4 transfectants were resistant to apoptosis induced by TGF-b1. In conclusion, these data suggest that PDCD4 is a proapoptotic molecule involved in TGF-b1-induced apoptosis in human HCC cells, and a possible tumor suppressor in hepatocarcinogenesis.
Introduction
Tumorigenesis is a multiple stage process that accompanies genetic alterations, including activation of oncogenes and inactivation of tumor suppressor genes (Fearon and Vogelstein, 1990; Hanahan and Weinberg, 2000) . Many tumor suppressor genes are reported to be downregulated in human cancers, and subsequent loss of tumor suppressor function is believed to contribute to the development of cancer. In human hepatocellular carcinoma (HCC), some tumor suppressor genes, including p53, M6P/IGF2R, p16INK4A, b-catenin, and retinoblastoma, are reported to be mutated or downregulated as compared with noncancerous liver (Ozturk, 1999; Buendia, 2000) . Furthermore, restoration of some of these genes is reported to reduce the malignant phenotype (Horowitz, 1999; Rider et al., 2002; Huang et al., 2003) , indicating important roles of the tumor suppressor genes in HCC development.
The programmed cell death 4 (PDCD4) gene was first isolated from a human glioma cell complementary DNA (cDNA) library as a tumor-related gene Yoshinaga et al., 1997 Yoshinaga et al., , 1999 and mapped to chromosome10q24 (Soejima et al., 1999) . Its expression was controlled by interleukins in human natural killer (NK) and T cells (Azzoni et al., 1998) . Mouse PDCD4 gene expression has been shown to be upregulated on induction of apoptosis in several systems (Shibahara et al., 1995; Juriscova et al., 1998) and to be downregulated by topoisomerase inhibitors (Onishi et al., 1998) . The mouse PDCD4 gene was shown to inhibit 12-O-tetracanoyl phorbol ester (TPA)-induced neoplastic transformation of epidermal cells and therefore regarded as a tumor suppressor gene (Cmarik et al., 1999) . With respect to molecular mechanisms of Pdcd4 function, the mouse Pdcd4-protein interacted with AP-1 and inhibited its transactivation, which may result in the suppression of tumor promotion (Yang et al., 2001 (Yang et al., , 2003a Young et al., 2003; Jansen et al., 2005) . Besides these activities of Pdcd4, the protein may also function via other signaling pathways. The Pdcd4-protein contains MA-3 domains homologous to the translation factor elF4G that binds to the RNA helicase elF4A (Aravind and Koonin, 2000) . It was shown that the mouse Pdcd4-protein directly interacts with elF4A, blocking its binding to elF4G, and modulating protein translation by inhibiting the initiation of Cap-dependent translation (Yang et al., 2003b , Jansen et al., 2005 . On the other hand, Kang et al. (Kang et al., 2002) showed that the expression of human PDCD4 is related to cellular senescence and the PDCD4-protein interacted with elF4G and the ribosomal protein S13 (RPS 13). Moreover, expression of PDCD4 was regulated by the transcription factor myb in chicken systems (Schlichter et al., 2001a, b) . The chicken PDCD4-protein shuttled between the nucleus and cytoplasm and bound to RNA, indicating that the protein may be involved in nuclear RNA metabolism (Bohm et al., 2003) . Therefore, these data suggest the involvement of PDCD4 in cellular growth and transformation.
Recently, it was reported that the levels of PDCD4-protein were downregulated in human lung cancers, and closely associated with potential for malignancy . However, expression and function of PDCD4 in human tumors and regulatory mechanisms of its expression are largely unknown. We therefore examined the expression of PDCD4 in human HCC tissues, and investigated the function of PDCD4 in human HCC cells. We report that PDCD4-protein is downregulated in human HCC tissues, and that PDCD4 is a proapoptotic molecule and involved in transforming growth factor-b1 (TGF-b1)-induced apoptosis in human HCC cells.
Results

Expression of PDCD4 in HCC and corresponding hepatic tissue
To investigate the levels of PDCD4-protein, an anti-PDCD4-protein antibody was raised against the N-terminal 14 amino acids of PDCD4 and its specificity was investigated. As shown in Figure 1a , the antibody recognized only one band of 65 kDa (lane a) on the Western blot of Huh7 cell extract, and this band disappeared when the antibody was absorbed with antigen peptide (lane b). The 65 kDa band also was detected in mouse NIH3T3 cells transfected with the PDCD4 plasmid but not in mock transfected cells (Figure 1a , lanes PDCD4 and mock). The antibody did not react with the PDCD4 isomer H731-protein produced in Escherichia coli (data not shown). These results indicate that the antibody specifically reacted with human PDCD4-protein.
Eighteen pairs of HCC and corresponding noncancerous liver tissues were analysed by Western blot using the anti-PDCD4 antibody. Clinical characteristics of these 18 patients were previously described (Ozaki et al., 2000) . Ten representative results from the 18 pairs are shown in Figure 1b . The levels of PDCD4-protein were downregulated in HCC tissues as compared with their corresponding noncancerous tissues in all cases tested, although the levels of downregulation were different in each case. The relative amount of PDCD4 protein expression was quantitated by densitometric scanning and corrected by b-actin expression. As shown in Figure 1c , the relative PDCD4 protein expression level Figure 1d , left panel). The positive staining was abolished when the antibody was absorbed with the antigen peptide ( Figure 1d , right panel), indicating that the staining of hepatocytes was specific for PDCD4. Sixteen pairs of HCC and noncancerous liver tissues obtained from 16 patients tested gave similar results in all cases, which were summarized in Table 1 .
PDCD4-induced apoptosis of human HCC-derived Huh7 cells As PDCD4-protein was downregulated in HCC tissues compared to noncancerous liver tissues, we introduced PDCD4 into the HCC cell line, Huh7, to investigate the function of PDCD4. When Huh7 cells were transfected with PDCD4 cDNA fused with DsRed, PDCD4-conjugated red color was observed in the cytoplasm and nucleus (Figure 2A-a) . The cells in which red color accumulated in the nucleus (with arrows) showed nuclear fragmentation characteristic of apoptosis when stained with Hoechst 33342 (Figure 2A-b) . It was also observed that the cells with nuclear accumulation of PDCD4-protein underwent nuclear fragmentation, when the cells were transfected with PDCD4-plasmid and stained with anti-PDCD4 antibody; as shown in Figure 2 A(d-g). DNA laddering was observed on electrophoresis of the DNA extracts derived from PDCD4-transfected Huh7 cells ( Figure 2B ). These results indicate that PDCD4 overexpression induced apoptosis of Huh7 cells. To investigate whether the apoptotic induction is propagated via mitochondria events and the caspase cascade, the levels of Bax and cytochrome c in the mitochondria and cytosol were examined by Westernblot analysis. As shown in Figure 2C , PDCD4 transfection into Huh7 cells resulted in increases of cytosolic cytochrome c and mitochondrial Bax, that accompanied with decreases of mitochondrial cytochrome c and cytosolic Bax. Furthermore, a slight reduction of procaspase-8 and significant reductions of procaspase-9 and -3 were observed after PDCD4 transfection in Huh7 cells ( Figure 2C ). In addition, a 2.5-fold increase of caspase-3 activity was observed by colorimetric assay in PDCD4 transfected cells compared with mock transfected cells ( Figure 2D ). These results indicated that PDCD4 might induce apoptosis via mitochondria events and caspase cascade.
TGF-b1-induced apoptosis and PDCD4 expression in Huh7 cells
It is known that TGF-b1 induces apoptosis in human HCC cell lines via mitochondrial events and caspase cascade activation (Shima et al., 1999) . Consistent with these data, our results showed that TGF-b1 induced apoptosis of Huh7 cells in a time-dependent manner, as revealed by DNA laddering ( Figure 3A ), Hoechst staining of cells ( Figure 3B ) and TUNEL assay ( Figure 3C ). When TGF-b1 treated cells were stained with Annexin-V, positive cells began to be observed at least at 6 h after addition of TGF-b1, and a result was obtained at 12 h after addition of TGF-b1 was shown in Figure 3D . However, the amount of positive cells was not significantly accumulated during TGF-b1 treatment (will be reported in detail elsewhere). Furthermore, increases of mitochondrial Bax and cytosolic cytochrome c were observed accompanied with decreases of cytosolic Bax and mitochondrial cytochrome c, slight reduction of procaspase-8, and significant reduction of procaspase-9, and -3 after induction of Huh7 cells by TGF-b1 ( Figure 3E ). Caspase-3 activity also was induced in TGF-b1-treated Huh7 cells ( Figure 3F ). However, the TGF-b1 signaling pathway that induces the mitochondrial events is not entirely elucidated. When total RNA obtained from TGF-b1-induced Huh7 cells was subjected to real-time RT-PCR using PDCD4 primers, the levels of PDCD4 mRNA were upregulated in the presence of TGF-b1 (Figure 4a, upper panel) . Simultaneously, the levels of PDCD4-protein also were upregulated in the presence of TGF-b1 as revealed by Western-blot analysis (Figure 4a , lower panel). The PDCD4-protein was usually localized in the cytoplasm of Huh7 cells (Figure 4b , control), but accumulated in the nuclei at 24 h after the addition of TGF-b1 (Figure 4b , TGF-b1).
In order to investigate the time-dependent nuclear accumulation of PDCD4, cytoplasmic and nuclear fractions of TGF-b1-treated Huh7 cells were subjected to Western-blot analysis using the anti-PDCD4 antibody and apoptotic cell number was counted simultaneously. An antibody against aldolase A that is a cytoplasmic protein (Kitajima et al., 1991) and an antibody against the nuclear protein histone H1, were employed to check the cross-contamination of cytoplasmic and nuclear fractions. Aldolase A was not detectable in the nuclear fractions and histone H1 was not detected in the cytoplamic fractions, as shown in Table 1 Staining levels of human HCC and liver tissues with anti-PDCD4 antibody
Number of samples
Staining levels 0 À (Equal staining levels with none-immune or antigen-absorbed antibody) 9 7 (Tissues with less than 30% positive area) 7 + (Tissues with more than 30% positive area) 0 ++ (Staining levels of normal tissues)
Sixteen pairs of HCC and liver tissues obtained from 16 patients were stained with non-immune and anti-PDCD4 antibody. All of the HCC tissues were stained less than their corresponding liver tissues, but more or less contained positive area as compared with negative controls stained with non-immune or antigen-absorbed anti-PDCD4 antibody ( Figure 1d ).
PDCD4 in TGF-b1-induced apoptosis H Zhang et al Figure 5 (upper panel). PDCD4 amounts in the nuclei increased parallel to the increases of apoptotic cells detected by Hoechst staining (the curve is essentially similar to that obtained by TUNEL assay in Figure 3C ) and reached a maximum at 24 h, while the amounts in the cytoplasm were approximately same levels until the amount of nuclei reached maximum after the addition of TGF-b1 ( Figure 5 , lower panel). This phenomenon was reproducibly observed in repeated experiments, indicating the nuclear accumulation of PDCD4 before apoptosis. Figure 5 also showed that histone H1 was lost from the nuclear fraction at 36-48 h, probably due to nuclear fragmentation during apoptosis.
To further identify that the PDCD4 gene is a target of TGF-b1 signaling pathway, we transiently expressed Smad7, which antagonizes TGF-b1-mediated Smad signaling, in Huh7 cells (Nakao et al., 1997) . Elevated expression of Smad7 was detected by Western blot in the cells after Smad7 transfection (Figure 6a ). TGF-b1 failed to induce growth inhibition ( Figure 6b Finally, to exclude that TGF-b1 may exert the proapoptotic effects through unspecific stimulation of receptors, constitutively active and kinase-defective TGF-b type I receptor were introduced into Huh7 cells, and PDCD4 protein levels were assayed by Western blotting. As shown in Figure 7a , transfection of constitutively active TGF-b type I receptor plasmid (TbR1-TD) stimulated expression of PDCD4 protein without TGF-b1 stimulation, although transfection of wild-type receptor plasmid showed no effect on the level of PDCD4 (data not shown). To examine the effects of kinase-defective receptor (TbR1-KR) on PDCD4 expression, Huh7 cells transfected with TbR1-KR plasmid were treated with and without 5 ng/ml TGF-b1 and surviving cells after 24 h were subjected to Western-blot analysis. As shown in Figure 7b , the amount of the receptor increased but that of PDCD4 decreased in the cells surviving from the TGF-b1 treatment as compared with those of TGF-b1-untreated cells, respectively. These results indicated that TGF-b1 stimulated PDCD4 expression via TGF b1 receptor-mediated signaling pathway.
PDCD4 is required in TGF-b1-induced apoptotic pathways
To confirm whether PDCD4 is involved in the TGF-b1-induced apoptosis in HCC cells, antisense PDCD4 stable transfectants of Huh7 were isolated. As shown in Figure 8a , PDCD4-protein levels were decreased, and were not significantly upregulated by treatment of cells with TGF-b1 in the PDCD4 antisense stable transfectant cell lines, Ash 2 and Ash 6, unlike a mocktransfected cell line. Eight of 12 PDCD4-antisensestable transfectant cell lines tested gave similar results and five mock-transfected cell lines were obtained, which showed similar levels of TGF-b1-induced apoptosis. The growth of the transfectants was then examined at 48 h after the addition of TGF-b1. Both transfectants were resistant to TGF-b1-induced growth inhibition as compared to the mock cells (Figure 8b) , and the number of apoptotic cells induced by TGF-b1 treatment was reduced in the PDCD4 antisense transfectants as compared to the mock cells as shown by Hoechst staining (Figure 8c) .
To examine the effects of the antisense construct on the levels of Bax and cytochrome c, transiently transfected Huh7 cells with antisense PDCD4 were treated with TGF-b1 and the levels of cytochrome c and Bax in the cytosol and mitochondria fractions were examined by Western blot. In contrast to the results obtained from Huh7 cells transfected with PDCD4 ( Figure 3E ), no significant changes in cytochrome c, Bax, and caspase-3 activity were observed in Huh7 cells transfected with antisense PDCD4 after TGF-b1 treatment (data not shown). These results indicated that PDCD4 is involved in the TGF-b1-induced apoptosis of Huh7 cells.
Discussion
In this report, we showed downregulation of PDCD4-protein in human HCC tissues compared to corresponding nontumoral liver tissues and the involvement of PDCD4 in TGF-b1-induced apoptotic signaling pathways in the HCC cell line Huh7. In other HCC cell lines, TGF-b1 induced apoptosis of Hep3B but not of HepG2 cells (Jang et al., 2002; Zhang et al., 2004) . We have observed that PDCD4 expression was upregulated in Hep3B but rarely in HepG2 cells by TGF-b1 treatment (unpublished data). Recently, Afonia et al. (2004) have reported that PDCD4 overexpression induced apoptosis PDCD4 in TGF-b1-induced apoptosis H Zhang et al of breast cancer cells, indicating the presence of PDCD4-mediated apoptotic pathway in other cell types. In our present data, PDCD4-antisense expression was less effective for the recovery of cell growth inhibited by TGF-b1 than for that by Smad7 (compare Figures 6b and 8b ) despite PDCD4 expression was almost depressed by the antisense construct. A different signaling pathway also might be present in the TGF-b1-induced apoptosis of Huh7 cells as shown in Hep3B (Jang et al., 2002) .
PDCD4 is widely expressed in human tissues (Azzoni et al., 1998; Yoshinaga et al., 1999; Kang et al., 2002; Chen et al., 2003) and several regulatory mechanisms of PDCD4 expression have been reported. Human PDCD4 (E) TGFb1 induced mitochondrial increase of Bax, cytosolic increase of cytochrome c, and changes in procaspase-8, -9, and -3 in Huh7 cells. Cells were treated with 5 ng/ml of TGF-b1 for the indicated times, mitochondria were separated from cytosol, and Bax, cytochrome c, procaspase-8, -9, -3 were analysed by Western blot. b-actin and MnSOD were used as controls for cytosol and mitochondria, respectively. (F) TGF-b1 induced caspase-3 activity in Huh7 cells. Cells were cultured for the indicated times in the presence of 5 ng/ml TGF-b1 and caspase-3 activity was examined by a plate reader at 405 nm. Data are expressed as OD per milligram of protein. *Po0.05 and **Po0.01 compared with that of 0-h treatment. Abbreviations: FITC, fluorsecein isothiocyanate; MnSOD, Manganase superoxide dismutase; PDCD4, programmed cell death 4 gene; PI, propidium iodide; TGF-b1, transforming growth factor-b1; TUNEL, TdT mediated dUTP nick end labelling; OD, optical density.
PDCD4 in TGF-b1-induced apoptosis
H Zhang et al gene expression is controlled by interleukins in NK cells (Azzoni et al., 1998) and upregulated by Vitamin A in breast cancer cells (Afonia et al., 2004) . In chicken cells, PDCD4 gene expression is regulated by the transcription factor, myb-1 (Schlichter et al., 2001a, b) . However, regulation of PDCD4 by TGF-b1 has not been studied. TGF-b1 is a potent growth inhibitor of normal hepatocytes and HCC cells and induces apoptosis in these cells (Bissell et al. 2001) . TGF-b exerts its biological effects through its cell surface complex of type I and type II receptors (Bissell et al., 2001; Shi and Massague, 2003) . After ligand binding, the activated receptor complexes propagate the signal through phosphorylation of Smad proteins to the nucleus where the activated Smad complexes act as transcriptional activators via interaction with a variety of transcription factors. TGF-b signaling also is modulated by the inhibitory Smad, Smad6 or Smad7. Our present data showed that Smad7 inhibited PDCD4 expression and constitutively active TGF-b1 type I receptor stimulated PDCD4 expression. These results indicated that PDCD4 expression was controlled via the TGF-b1 receptor-mediated signaling pathway induced by TGF-b1. However, TGF-b1 is highly expressed in many malignant tumors including HCC, and tumor cells are frequently thought to have lost sensitivity to TGF-b1 (Matsuzaki et al., 2000; Wong and Lai, 2001) . Although several mechanisms are proposed to explain this loss of sensitivity in HCC cells, the precise molecular mechanisms remain to be elucidated. The data presented here show that HCC cells transfected with antisense PDCD4 have less apoptosis induced by TGF-b1. The results suggest that decreased PDCD4 expression in HCC might, in part, explain the decreased sensitivity to TGF-b1. Another mechanism to (a) Cells were cultured for indicated times in the presence of 5 ng/ml TGF-b1. Expression of PDCD4 was analysed by real-time RT-PCR and Western blot. RT-PCR; PDCD4 mRNA was determined by the TaqMan Gene Expression Assay System using a standard PDCD4 cDNA. GAPDH as a control was determined as well using a RNA standard. Reverse transcription (RT) was performed at independently diluted two different concentrations of RNA and each RT reaction mixture was determined by duplicated PCR. Both expressions were represented as % of those at 0 h. Western blot: Cells cultured with 5 ng/ml TGF-b1 were analysed at the indicated times using anti-PDCD4 antibody and anti-b-actin antibody as a control. (b) TGF-b1 induced nuclear accumulation of PDCD4 protein in Huh7 cells. Cells were treated without (Control) or with 5 ng/ml of TGF-b1 (TGF-b1) for 24 h, then fixed and stained with anti-PDCD4 antibody. Abbreviations: cDNA, complementary DNA; GAPDH, glyceraldehyde-3-phosphate dehydrogenase, PCR, polymerase chain reaction; PDCD4, programmed cell death 4; TGF-b1, transforming growth factor-b1. PDCD4 in TGF-b1-induced apoptosis H Zhang et al explain loss of sensitivity is downergulation of TGF-b1 receptors. It was reported that TGF-b1 receptors, mainly type II receptors were downregulated in HCC cells (Paik et al, 2003 , Musch et al, 2005 , although we could not observe decreases of the receptors in several HCC tissues so far tested (unpublished data). The observation that PDCD4 levels were downregulated in the cancer cells, supports the results by Cmarik et al. (1999) in which the mouse PDCD4-protein inhibited neoplastic transformation of epidermal cells and was detrimental for transformed cells. Therefore, PDCD4 might play a tumor-suppressor function during hepatocarcinogenesis. Downregulation of several genes considered to act as tumor suppressors such as p16, p27, Rb, and p53, were reported in human HCC (Ozturk, 1999; Buendia, 2000) . The mechanisms of downregulation of these genes include point mutations, loss of heterozygosity (LOH), and/or transcriptional repression by altered DNA methylation. The locus of PDCD4 is assigned to 10q24 (Soejima et al., 1999) , and deletion of this region was reported in some cases of HCC (Nagai et al., 1997; Kusano et al., 1999) . However, deletion of PDCD4 locus is noted only in minor cases of HCC, PDCD4 in TGF-b1-induced apoptosis H Zhang et al while PDCD4 protein levels were decreased in all cases of HCC studied here. Therefore, mechanism(s) other than LOH or point mutation should be present in the downregulation of PDCD4-protein. Downregulation of TGF-b1 receptors might be one of mechanisms to depress PDCD4 expression in HCC. We have shown partial molecular mechanisms responsible for apoptosis of Huh7 cells by PDCD4 through mitochondrial events and caspase activation, but the mechanisms by which PDCD4 induces mitochondrial events are largely unknown. Although it was recently reported that the mouse PDCD4-protein inhibits the transactivation activity of AP-1, and that the PDCD4-protein interacted with translation initiation factor eIF4AI in the cytoplasm and inhibited capdependent translation by inhibiting the RNA helicase activity of eIF4A (Yang et al., 2003b , Jansen et al., 2005 , it is unclear whether these mechanisms are involved in the PDCD4-induced apoptosis. Other molecular targets of PDCD4 might present in cells, considering that many kinds of proteins contain elF4G M1/PDCD4Ma-3 domains (Aravind and Koonin, 2000; Simmons et al, 2005) . Interestingly, our previous data demonstrated that PDCD4 protein was localized in the cytoplasm or nucleus or both depending on cell type, and it was shown that PDCD4 protein accumulated in nuclei at the G 0 -phase of human normal fibroblasts ). An anti-PDCD4-antibody revealed that the protein localized to the nuclei of breast ductal cells and also in well-differentiated adenocarcinoma of the breast, but apoptotic figures were not observed in both cases . Our present data show that PDCD4 protein was usually localized in the cytoplasm, but accumulated in nuclei, which were apoptotic after TGF-b1 treatment of Huh7 cells. Furthermore, the time course of nuclear accumulation of PDCD4 was parallel to that of apoptosis. As these data suggest that accumulation of PDCD4 in the nuclei is important for apoptosis, the control mechanisms of the localization of PDCD4 protein may play an important role in inducing apoptosis. Further investigation is required to elucidate the relationship between nuclear accumulation of PDCD4 and apoptosis via mitochondrial events induced by PDCD4.
Recently, it was reported that PDCD4 enhanced the sensitivity of cancer cells to anticancer drugs such as geldanamycin and tamoxifen (Jansen et al., 2004) . Altogether, these data and our results suggest that PDCD4 may have potential value as a molecular target in cancer therapy (Lankat-Buttgereit and Go¨ke, 2003) .
Materials and methods
Human liver samples
Human liver specimens were obtained by surgical resection for the treatment of hepatic neoplasm or by autopsy performed within 3 h after death at Saga University Hospital. Clinical features of these cases were previously reported (Ozaki et al., 2000) . Of these 20 patients, 5 were female and 15 were male, with a mean age 7s.d. 
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Both HCC and corresponding uninvolved liver tissues were subjected to Western analysis for PDCD4 in 18 cases. In 16 cases, specimens were subjected to immunohistochemical analysis of PDCD4 expression. All procedures were performed with informed consent at Saga University Hospital.
Plasmids and transfection
Programmed cell death 4 gene cDNA plasmid was isolated from a human heart cDNA library directionally conjugated in the pCMV-SPORT (Life Technologies, Carlsbad, CA), and used for transfection of HCC cells. pDsRed2-N1-PDCD4 was prepared by conjugating PDCD4 at the DsRed2-N-terminal in pDsRed2-N1 vector (Clontech, Palo Alto, CA) according to the manufacturer's protocol. Antisense PDCD4 plasmid was prepared by connecting the H731 whole sequence which covers PDCD4 whole sequence with EcoRV -XbaI sites of pcDNA3 vector in the anti-sense direction. Human Smad7 plasmid conjugated as the cDNA under the cytomegalovirus (CMV) promoter of pcDNA3 (Nakao et al., 1997) , and wild-type (TbR1), constitutively active (TbR1-TD) and kinase-defective (TbR1-KR) TGF-b type I receptor plasmids conjugated with pcDNA3 vector (Wieser et al, 1995) were obtained from Dr Heldin (Ludwig Institute for Cancer Research, Upsala, Sweden). Transfection of HCC cells with plasmids was performed using Lipofectamine and Plus reagents or Lipofectamine 2000 according to the manufacturer's protocols (Invitrogen Corp., Carlsbad, CA).
Antibodies
An anti-PDCD4 antibody was prepared by immunizing rabbits with a synthetic peptide corresponding to the N-terminal 14 amino acids (DVENEQILNVNPAD) conjugated with Keyhole Limpet hemocyanin (Hokkaido System Science, Sapporo, Japan), and partially purified as described previously . Rabbit polyclonal antibodies to Bax (used at 1:500 dilution), cytochrome c (1:500), Histone H1 (1:200) and Smad7 (1:500) were purchased from Santa Cruz Biotechnology (CA). Antibodies against procaspase-8 (1:1000), procaspase-9 (1:1000), procaspase-3 (1:1000) and TGF-b type I receptor (1:1000) were purchased from Cell Signaling Technology Inc. (Beverly, MA). The anti-b-actin antibody (1:500) was purchased from Biomedical Technologies (Stoughton, MA). Anti-MnSOD (Manganase superoxide dismutase) (1:2000) purchased form Upstate (Charlottesville, VA), was used for the detection of MnSOD as a control of mitochondria protein (Akao et al., 1994) . The anti-aldolase A monoclonal antibody 4C-2 was prepared as previously reported (Kitajima et al., 1991) .
Cell proliferation and apoptosis
The human HCC derived cell line, Huh7, was cultured and maintained in Dulbecco's modified Eagle's medium (DMEM) (GIBCO-BRL, Gaithersburg, MD) containing 10% fetal calf serum (GIBCO-BRL). The sensitivity of HCC cell lines to TGF-b1 (R&D Systems, Minneapolis, MN) was determined by the WST-1 cell proliferation assay kit (Takara, Kyoto, Japan) according to the manufacturer's protocol.
For the analysis of DNA laddering characteristic of apoptotic cell death, cells were resuspended in lysis buffer containing 10 mM EDTA, 10 mM Tris (pH 8.0), and 0.5% Triton X-100 at 41C for 10 min and centrifuged at 16 000 r.p.m. for 20 min. The supernatant was treated with RNase A at 371C for 1 h and then with proteinase K at 501C for 30 min, followed by precipitation with isopropanol. The DNA precipitate was resuspended, and electrophoresed in a 2% agarose gel. Morphological changes in the nuclear chromatin of HCC cells undergoing apoptosis were detected by staining with Hoechst 33342 (Wako, Osaka, Japan) (Suzuki et al., 1999) . One thousand cells were observed in five randomly chosen areas for each sample. Cells with condensed or fragmented nuclei were considered to be apoptotic. TUNEL and Annexin-V assays were performed using kits purchased from MBL (Nagoya, Japan) according to manufacturer's protocols, respectively. The data are expressed as the percentage of apoptotic cells.
RNA extraction and RT-PCR
Total RNA of cells was extracted using ISOGEN (Nippon Gene, Tokyo, Japan) according to the manufacturer's protocol. Real-time PCR was performed by TaqMan Gene Expression Assay system (Applied Biosystems, Foster City, CA) using exon 2 and 4 of PDCD4 and GAPDH as a control according to the manufacturer's protocols.
Western blot
The protein from tissues and cells was extracted by a lysisbuffer containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% SDS, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg/ml soybean trypsin inhibitor and 50 mM iodoacetamide. Protein amounts were determined by a protein assay kit (Bio-Rad, Hercules, CA) using bovine serum albumin (BSA) as a standard. Forty micrograms of protein of each sample was mixed with NuPAGE sample buffer (Novex, San Diego, CA) and separated on SDS-10 or 15% polyacrylamide gel. The bands in the gels were electrophoretically transferred to a polyvinylidene difluoride (PVDF) membrane (Bio-Rad). The membrane was then blocked by incubating with 5% skim milk in phosphate-buffered saline (PBS) containing 0.1% Tween 20 for 1-2 h at room temperature, followed by incubation with primary antibody for 30 min at room temperature. The specific bands were visualized by further incubation with HRP (Horseradish peroxidase)-conjugated second antibody followed by a chemiluminescence reaction using the ECL system (Amersham, Buckinghamshire, England) according to the manufacturer's instructions. The rabbit polyclonal anti-b-actin antibody (Biomedical Technologies) was used as a control. The antibody against MnSOD which is a mitochondria marker (Akao et al., 1994) and anti-Histone H1 antibody were used as controls of mitochondria and nuclear fractions, respectively.
Immunohistochemical analysis for PDCD4
Paraffin sections (5 mm) were stained with anti-PDCD4 antibody by incubating overnight at 41C. Secondary staining with biotin-conjugated anti-rabbit IgG and tertiary staining with HRP-conjugated streptoavidin, were performed by an ABC kit (VECTASTAIN, Vector Labs, Burlingame, CA). Specific stainings were visualized by 3,3 0 -diaminobenzidine (DAB) staining. The slides were then counterstained with hematoxylin. Cells were cultured in the Lab-Tek chamber glass slide (Nalgen Nunc International, Rochester, NY), fixed by incubating for 10 min with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, followed by treatment for 1 min with cold acetone. The fixed cells were immunostained in the same way as the paraffin sections described above without counterstaining by hematoxylin.
Subcellular fractionation of cells
Subcellular fractionation of cytosol and mitochondria was performed according to the method described previously (Suzuki et al., 1999) . Briefly, harvested cells were suspended in a hypotonic buffer (250 mM sucrose, 20 mM HEPES/KOH pH 7.5, 1.5 mM MgCl 2 , 10mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupetin, and 1.8 mg/ml iodoacetamide), passed through a 25-gauge needle and centrifuged at 1000 r.p.m. for 10 min at 41C. Supernatants were further centrifuged at 10000 r.p.m. for 15 min at 41C. The pellets were used as the mitochondrial fraction. The supernatants were ultracentrifuged at 100 000 g for 60 min at 41C, and the resulting supernatants were used as the cytosolic fraction. Cytoplasmic and nuclear fractions were obtained by NE-PER kit (Pierce, Biotechnology Inc, Rockford, IL) according to the manufacturer's protocol. The nuclear fraction was further extracted with 0.6 M NaCl containing 10 mM Hepes, 5 mM MgCl2, 0.5 mM CaCl2, 0.5% NP40, 1% Triton-X100, 1 mM PMSF, 10 mg/ml leupeptin and 10 mg/ml aprotinin.
Caspase-3 activity assay Caspase-3 activity was determined using a colorimetric CaspACE Assay System (Promega, Madison, WI) according to the manufacturer's instructions. Briefly, harvested cells were lysed by subjecting to four cycles of freezing and thawing, and centrifuged at 15000 g for 20 min at 41C. The same amount of protein was added to a 96-well plate and then the following items were added into each well: 32 ml caspase assay buffer, 2 ml DMSO, 10 ml of 100 mM DTT, and 2 ml of 10 mM Ac-DEVDpNA substrate in 100 ml final volume. Blank (without cell extracts) and negative control (with pan-caspase inhibitor Z-VAD-FMK) reaction mixtures also were prepared simultaneously. After incubation at 371C for 4 h, the absorbance of the reaction mixtures was measured by a plate reader at 405 nm. Caspase activity was determined in triplicate, and results of caspase-3 activity were expressed as optical density (OD) per 1 mg of protein.
Statistical analysis
Differences were determined using Student's t-test, and Po0.05 was considered significant. All experiments were performed in triplicate or more. Data are shown as the mean7standard deviation (s.d.).
Abbreviations PDCD4, programmed cell death 4; HCC, hepatocellular carcinoma; TGF-b1, transforming growth factor-b1; RT-PCR, reverse transcription-polymerase chain reaction; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
